Continue reading your story on the app
Continue reading your story in the magazine
“We are particularly looking forward to increasing our business in India”
Emerging from the Institute of Cell Culture Technology at Bielefeld University, Germany, in 2009, Xell AG (formerly TeutoCell AG), has grown to become an independent and privately financed biotech company dedicated to cutting-edge innovation and developing expertise. With more than 20 years of hands-on experience in cell culture technology, Xell has drawn from its academic and technological knowledge to become a key partner in the design and distribution of cell culture solutions. The company is currently serving the Indian market through its partnership with Navi Mumbai-based Rane Rao Reshamia Laboratories. BioSpectrum interacted with Prof. Thomas Noll, Chairman, Supervisory Board, Xell AG, Germany to find out more about the company’s plans for 2021 and beyond. Edited excerpts;
BioSpectrum honours INDUSTRY STALWARTS
It is time to celebrate the outstanding contribution and achievements of the Indian Bio Sciences industry leaders and organisations over the past one year.
Building On Biologics Business Growth
In 1990’s when Hasmukh K Chudgar, founder of Intas Pharmaceuticals handed over the company to his sons Binish, Nimish and Urmish, the company’s turnover was less than $1 million.
King Of Vaccines Protecting Children From Birth Onwards
Son of a horse breeder, Cyrus Poonawalla founded Serum Institute of India (SII) in 1966 in Pune when he was just 22 years and got married to Villoo. Over the years, his passion of offering affordable vaccines to the world has motivated to build SII into one of the world’s largest vaccine makers.
“We support scientists in all regions researching and developing vaccines against COVID”
Eva van Pelt, Co-CEO & Chief Commercial Officer, Eppendorf AG, Hamburg, Germany
NECHRI, IIT-G ink MoU for cancer research
Indian Institute of Technology, Guwahati (IIT-G), has signed a Memorandum of Understanding (MoU) with North East Cancer Hospital and Research Institute (NECHRI), Jorabat, Assam.
“Peptide purification market is underserved by traditional resin suppliers”
« Jonathan Royce, Chief Executive Officer, Bio-Works Technologies AB, Sweden
India rolls out vaccines to neighbouring coThe government has opened a new institute of Council of Scientific and Industrial Research (CSIR) i.e. CSIR-National Institute of Science Communication and Policy Research (CSIR-NIScPR), in New Delhi.untries
The Government of India has received several requests for the supply of Indian manufactured vaccines from neighbouring and key partner countries.
LEADING FROM THE FRONT
The International Women’s Day theme for 2021, celebrated on March 8 every year, is #ChooseToChallenge, which highlights the importance of challenging biases and misconceptions in the interest of creating a more inclusive and gender-equal world.
CEPI Call provides up to $140M to vaccine developers
Norway based Coalition for Epidemic Preparedness Innovations (CEPI) has opened a new funding opportunity to support the rapid generation of additional clinical research on COVID-19 vaccines.